Back
BridgeBio Pharma Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
BBIO
BridgeBio Pharma
Last Price:
$47.10
Seasonality Move:
8.94%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing slight selling pressure.
BridgeBio Pharma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.9 | Buy |
20-day SMA: | 44.14 | Buy |
50-day SMA: | 39.18 | Buy |
200-day SMA: | 32.42 | Buy |
8-day EMA: | 46.11 | Buy |
20-day EMA: | 44.09 | Buy |
50-day EMA: | 40.64 | Buy |
200-day EMA: | 34.36 | Buy |
BridgeBio Pharma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.2 | Buy |
Relative Strength Index (14 RSI): | 70.28 | Buy |
Chaikin Money Flow: | -431753 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.72 - 45.88) | Buy |
Bollinger Bands (100): | (32.44 - 41.12) | Buy |
BridgeBio Pharma Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for BridgeBio Pharma Stock
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 47.10 while BBIO 8-day simple moving average is 45.90, which is a Buy signal.
-
The stock price of BBIO is 47.10 while BridgeBio Pharma 20-day SMA is 44.14, which makes it a Buy.
-
BridgeBio Pharma 50-day simple moving average is 39.18 while BBIO share price is 47.10, making it a Buy technically.
-
BBIO stock price is 47.10 and BridgeBio Pharma 200-day simple moving average is 32.42, creating a Buy signal.
BBIO Technical Analysis vs Fundamental Analysis
Sell
50
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy or a Sell?
-
BridgeBio Pharma stock is rated a SellThe current BridgeBio Pharma [BBIO] share price is $47.10. The Score for BBIO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
BridgeBio Pharma Stock Info
Market Cap:
8.9B
Price in USD:
47.10
Share Volume:
2.6M
BridgeBio Pharma 52-Week Range
52-Week High:
48.68
52-Week Low:
21.72
Sell
50
BridgeBio Pharma (BBIO)
is a Sell
BridgeBio Pharma Share Price Forecast
-
What is the BridgeBio Pharma stock price today?The BridgeBio Pharma stock price is 47.10 USD today.
-
Will BBIO stock go up or go down?BridgeBio Pharma> share price is forecast to RISE/FALL based on technical indicators
-
Is BridgeBio Pharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BridgeBio Pharma is overvalued.
Is BridgeBio Pharma Stock a Buy?
-
BridgeBio Pharma share price is 47.10 while BBIO 8-day exponential moving average is 46.11, which is a Buy signal.
-
The stock price of BBIO is 47.10 while BridgeBio Pharma 20-day EMA is 44.09, which makes it a Buy.
-
BridgeBio Pharma 50-day exponential moving average is 40.64 while BBIO share price is 47.10, making it a Buy technically.
-
BBIO stock price is 47.10 and BridgeBio Pharma 200-day simple moving average is 34.36, creating a Buy signal.
Fundamental Analysis of BridgeBio Pharma
Is BridgeBio Pharma a good investment?
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.19 per share, an increase this year of $0.17 per share, and an increase next year of $0.47 per share.
Technical Analysis of BridgeBio Pharma
Should I short BridgeBio Pharma stock?
-
BBIO Moving Average Covergence Divergence (MACD) indicator is 2.2, suggesting BridgeBio Pharma is a Buy
-
BridgeBio Pharma Relative Strength Index (RSI) is 70.28, which suggest BridgeBio Pharma is overbought
-
The Bollinger Bands (25) for BridgeBio Pharma is (40.72 - 45.88), which suggest BridgeBio Pharma is a Buy
-
The Bollinger Bands (100) for BridgeBio Pharma is (32.44 - 41.12), which suggest BridgeBio Pharma is a Buy
* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.